{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:51:51Z","timestamp":1792669911169,"version":"4.5.0"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    An important worldwide problem is the resistance of\n                    <jats:italic>Plasmodium falciparum<\/jats:italic>\n                    to practically all antimalarial medications. Therefore, new treatment approaches are urgently needed. The development of antimalarial medications frequently involves\u00a0two important therapeutic targets: casein kinase 2 (CK2) and cGMP-dependent protein kinase (PKG). To identify naturally occurring chemicals that could be used as antimalarial medications to combat multidrug-resistant\n                    <jats:italic>P. falciparum<\/jats:italic>\n                    , we used a multi-targeted\n                    <jats:italic>in silico<\/jats:italic>\n                    strategy in this study. The top 20 compounds, including the reference drug RY-1\u201365, were selected after pharmacophore-based virtual screening of naturally produced compounds. These compounds were subsequently docked onto both target proteins using Maestro (Schr\u00f6dinger 2020\u22123). The best-scoring compounds against PKG and CK2 were Ligand-9 (\u22127.490 kcal\/mol) and Ligand-13 (\u221211.468 kcal\/mol), respectively. These lead compounds may be useful as therapeutic targets based on an assessment of their pharmacological, toxicological, and bioactivity characteristics. Furthermore, Ligand-13\u2019s strong reactivity and stability were demonstrated by density functional theory analysis, and these findings were confirmed by molecular dynamics simulations and binding free energy MMGBSA calculations. These results imply that Ligand-13 may be a promising antimalarial medication.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0339317","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T18:40:32Z","timestamp":1768329632000},"page":"e0339317","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Computational screening of natural inhibitors against Plasmodium falciparum kinases: Toward novel antimalarial therapies"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7858-8288","authenticated-orcid":true,"given":"Muharib","family":"Alruwaili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Younas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abozer Y.","family":"Elderdery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Intisar","family":"Alruwaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1719-9047","authenticated-orcid":true,"given":"Jeremy","family":"Millis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6289-5207","authenticated-orcid":true,"given":"Muhammad Umer","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6185-2042","authenticated-orcid":true,"given":"Hasan","family":"Ejaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"issue":"10","key":"pone.0339317.ref001","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S1473-3099(25)00499-2","article-title":"Malaria resurgence in Africa: confronting the challenges","volume":"25","author":"F Ntoumi","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"pone.0339317.ref002","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/microorganisms7060179","article-title":"Malaria: The Past and the Present","volume":"7","author":"J Talapko","year":"2019","journal-title":"Microorganisms"},{"issue":"3","key":"pone.0339317.ref003","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(24)00016-8","article-title":"The 2023 WHO World malaria report","volume":"5","author":"P Venkatesan","year":"2024","journal-title":"Lancet Microbe"},{"issue":"6","key":"pone.0339317.ref004","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.pt.2018.11.010","article-title":"Plasmodium falciparum","volume":"35","author":"AG Maier","year":"2019","journal-title":"Trends Parasitol"},{"key":"pone.0339317.ref005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijpddr.2020.11.006","article-title":"Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions - India and sub-Saharan Africa","volume":"15","author":"A Arya","year":"2021","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"1","key":"pone.0339317.ref006","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s12936-021-03890-0","article-title":"Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Mali: a systematic review and meta-analysis","volume":"20","author":"FO Maiga","year":"2021","journal-title":"Malar J"},{"issue":"1","key":"pone.0339317.ref007","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/femsre\/fuw037","article-title":"The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread","volume":"41","author":"CJ Woodrow","year":"2017","journal-title":"FEMS Microbiol Rev"},{"issue":"2","key":"pone.0339317.ref008","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/bcp.14474","article-title":"Advances and roadblocks in the treatment of malaria","volume":"88","author":"B Hanboonkunupakarn","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"pone.0339317.ref009","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025452","article-title":"Biology of malaria transmission","volume":"7","author":"E Meibalan","year":"2017","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"1","key":"pone.0339317.ref010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1128\/EC.00186-09","article-title":"The malaria parasite cyclic GMP-dependent protein kinase plays a central role in blood-stage schizogony","volume":"9","author":"HM Taylor","year":"2010","journal-title":"Eukaryot Cell"},{"key":"pone.0339317.ref011","doi-asserted-by":"crossref","first-page":"610408","DOI":"10.3389\/fmicb.2020.610408","article-title":"Plasmodium falciparum cGMP-Dependent Protein Kinase - A Novel Chemotherapeutic Target","volume":"11","author":"D Rotella","year":"2020","journal-title":"Frontiers in Microbiology"},{"key":"pone.0339317.ref012","doi-asserted-by":"crossref","first-page":"602803","DOI":"10.3389\/fmicb.2020.602803","article-title":"Targeting the Malaria Parasite cGMP-Dependent Protein Kinase to Develop New Drugs","volume":"11","author":"DA Baker","year":"2020","journal-title":"Front Microbiol"},{"key":"pone.0339317.ref013","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1741-7007-10-5","article-title":"Involvement of Plasmodium falciparum protein kinase CK2 in the chromatin assembly pathway","volume":"10","author":"EG Dastidar","year":"2012","journal-title":"BMC Biol"},{"issue":"1","key":"pone.0339317.ref014","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s42003-021-01873-0","article-title":"The catalytic subunit of Plasmodium falciparum casein kinase 2 is essential for gametocytogenesis","volume":"4","author":"E Hitz","year":"2021","journal-title":"Commun Biol"},{"issue":"12","key":"pone.0339317.ref015","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1021\/acsmedchemlett.1c00540","article-title":"Discovery of Imidazole-Based Inhibitors of Plasmodium falciparum cGMP-Dependent Protein Kinase","volume":"12","author":"RRY Bheemanaboina","year":"2021","journal-title":"ACS Med Chem Lett"},{"issue":"5","key":"pone.0339317.ref016","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1021\/acs.jmedchem.3c01795","article-title":"Structure-Activity Relationship of a Pyrrole Based Series of PfPKG Inhibitors as Anti-Malarials","volume":"67","author":"JA Gilleran","year":"2024","journal-title":"J Med Chem"},{"issue":"1","key":"pone.0339317.ref017","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/s12936-019-3026-1","article-title":"Antiplasmodial natural products: an update","volume":"18","author":"N Tajuddeen","year":"2019","journal-title":"Malar J"},{"key":"pone.0339317.ref018","first-page":"172","article-title":"Role of natural products in drug discovery process","volume":"6","author":"A Siddiqui","year":"2014","journal-title":"Int J Drug Dev Res"},{"issue":"1","key":"pone.0339317.ref019","doi-asserted-by":"crossref","DOI":"10.1186\/s42269-021-00690-z","article-title":"In-silico activity prediction, structure-based drug design, molecular docking and pharmacokinetic studies of selected quinazoline derivatives for their antiproliferative activity against triple negative breast cancer (MDA-MB231) cell line","volume":"46","author":"SH Abdullahi","year":"2022","journal-title":"Bull Natl Res Cent"},{"issue":"3","key":"pone.0339317.ref020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.29161\/PT.v7.i3.2019.31","article-title":"In silico Pharmacokinetics and Molecular Docking Studies of Lead Compounds Derived from Diospyros Mespiliformis","volume":"7","author":"AH Ahmed","year":"2019","journal-title":"PharmaTutor"},{"issue":"7","key":"pone.0339317.ref021","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.chembiol.2020.04.001","article-title":"Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity","volume":"27","author":"M Vanaerschot","year":"2020","journal-title":"Cell Chem Biol"},{"key":"pone.0339317.ref022","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/978-1-4939-7000-1_26","article-title":"Protein Data Bank (PDB): the single global macromolecular structure archive","volume-title":"Protein crystallography: methods and protocols","author":"SK Burley","year":"2017"},{"issue":"1","key":"pone.0339317.ref023","doi-asserted-by":"crossref","first-page":"7365","DOI":"10.1038\/s41598-018-25738-5","article-title":"The protein kinase CK2 catalytic domain from Plasmodium falciparum: crystal structure, tyrosine kinase activity and inhibition","volume":"8","author":"D Ruiz-Carrillo","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"pone.0339317.ref024","first-page":"1","article-title":"The Pharmit Backend: A Computer Systems Approach to Enabling Interactive Online Drug Discovery","volume":"62","author":"DR Koes","year":"2018","journal-title":"IBM J Res Dev"},{"issue":"1","key":"pone.0339317.ref025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"ZINC--a free database of commercially available compounds for virtual screening","volume":"45","author":"JJ Irwin","year":"2005","journal-title":"J Chem Inf Model"},{"key":"pone.0339317.ref026","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An open chemical toolbox","volume":"3","author":"NM O\u2019Boyle","year":"2011","journal-title":"J Cheminform"},{"issue":"6","key":"pone.0339317.ref027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0325281","article-title":"Linalool-based silver nanoconjugates as potential therapeutics for glioblastoma: in silico and in vitro insights","volume":"20","author":"H Manzoor","year":"2025","journal-title":"PLoS One"},{"issue":"1","key":"pone.0339317.ref028","doi-asserted-by":"crossref","first-page":"74","DOI":"10.6026\/97320630019074","article-title":"Molecular docking analysis of Indole based diaza-sulphonamides with JAK-3 protein","volume":"19","author":"M Nautiyal","year":"2023","journal-title":"Bioinformation"},{"issue":"8","key":"pone.0339317.ref029","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: New docking methods, expanded force field, and Python bindings","volume":"61","author":"J Eberhardt","year":"2021","journal-title":"J Chem Inf Model"},{"issue":"3","key":"pone.0339317.ref030","first-page":"101","article-title":"Molecular docking of red betel (Piper crocatum Ruiz & Pav) bioactive compounds as HMG-CoA reductase inhibitor","volume":"24","author":"BF Zaelani","year":"2021","journal-title":"Journal of Scientific and Applied Chemistry"},{"key":"pone.0339317.ref031","doi-asserted-by":"crossref","first-page":"112479","DOI":"10.1016\/j.ejmech.2020.112479","article-title":"Discovery of novel aminopiperidinyl amide CXCR4 modulators through virtual screening and rational drug design","volume":"201","author":"YH Oum","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"2","key":"pone.0339317.ref032","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1298","article-title":"Using PyMOL as a platform for computational drug design","volume":"7","author":"S Yuan","year":"2017","journal-title":"WIREs Comput Mol Sci"},{"key":"pone.0339317.ref033","volume-title":"Drug designing in discovery studio","author":"BL Jejurikar","year":"2021"},{"issue":"1","key":"pone.0339317.ref034","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13568-023-01640-w","article-title":"Natural compound targeting BDNF V66M variant: insights from in silico docking and molecular analysis","volume":"13","author":"A Sakhawat","year":"2023","journal-title":"AMB Express"},{"key":"pone.0339317.ref035","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"A Daina","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"pone.0339317.ref036","doi-asserted-by":"crossref","first-page":"27012","DOI":"10.1289\/EHP9341","article-title":"STopTox: An in Silico Alternative to Animal Testing for Acute Systemic and Topical Toxicity","volume":"130","author":"JVB Borba","year":"2022","journal-title":"Environ Health Perspect"},{"key":"pone.0339317.ref037","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"A Daina","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"pone.0339317.ref038","volume-title":"Gaussian 09, Revision D. 01","author":"M Frisch","year":"2009"},{"issue":"3","key":"pone.0339317.ref039","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1107\/S0021889808012016","article-title":"VESTA: a three-dimensional visualization system for electronic and structural analysis","volume":"41","author":"K Momma","year":"2008","journal-title":"J Appl Crystallogr"},{"issue":"1","key":"pone.0339317.ref040","doi-asserted-by":"crossref","first-page":"34076","DOI":"10.1038\/s41598-025-14557-0","article-title":"Citronellol silver nanoconjugates as a therapeutic strategy for glioblastoma through computational and experimental evaluation","volume":"15","author":"H Manzoor","year":"2025","journal-title":"Sci Rep"},{"issue":"3","key":"pone.0339317.ref041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0318539","article-title":"Identifying novel inhibitors against drug-resistant mutant CYP-51 Candida albicans: A computational study to combat fungal infections","volume":"20","author":"S Jabeen","year":"2025","journal-title":"PLoS One"},{"issue":"10","key":"pone.0339317.ref042","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1021\/acs.jcim.1c00998","article-title":"Making it rain: cloud-based molecular simulations for everyone","volume":"61","author":"PR Arantes","year":"2021","journal-title":"J Chem Inf Model"},{"issue":"1","key":"pone.0339317.ref043","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/pro.3923","article-title":"The Bio3D packages for structural bioinformatics","volume":"30","author":"BJ Grant","year":"2021","journal-title":"Protein Sci"},{"issue":"2","key":"pone.0339317.ref044","doi-asserted-by":"crossref","DOI":"10.1002\/cphc.202200491","article-title":"On the Uses of PCA to Characterise Molecular Dynamics Simulations of Biological Macromolecules: Basics and Tips for an Effective Use","volume":"24","author":"J Palma","year":"2023","journal-title":"Chemphyschem"},{"issue":"2","key":"pone.0339317.ref045","first-page":"298","article-title":"Principal component analysis and related methods for investigating the dynamics of biological macromolecules","volume":"5","author":"A Kitao","year":"2022","journal-title":"J"},{"issue":"11","key":"pone.0339317.ref046","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1007\/s00894-013-1997-3","article-title":"Binding selectivity studies of PKB\u03b1 using molecular dynamics simulation and free energy calculations","volume":"19","author":"S-F Chen","year":"2013","journal-title":"J Mol Model"},{"issue":"9","key":"pone.0339317.ref047","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21091222","article-title":"Molecular Modeling Studies of 11\u03b2-Hydroxysteroid Dehydrogenase Type 1 Inhibitors through Receptor-Based 3D-QSAR and Molecular Dynamics Simulations","volume":"21","author":"H Qian","year":"2016","journal-title":"Molecules"},{"issue":"2","key":"pone.0339317.ref048","doi-asserted-by":"crossref","first-page":"629","DOI":"10.21608\/bfsa.2022.271581","article-title":"Prospect of natural compounds against malaria: a review","volume":"45","author":"T Nain","year":"2022","journal-title":"Bulletin of Pharmaceutical Sciences Assiut University"},{"issue":"19","key":"pone.0339317.ref049","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.2174\/0929867328666210803152419","article-title":"Antimalarial Drug Discovery: From Quinine to the Most Recent Promising Clinical Drug Candidates","volume":"29","author":"C Tisnerat","year":"2022","journal-title":"Curr Med Chem"},{"issue":"10","key":"pone.0339317.ref050","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMc1612765","article-title":"Emergence of Indigenous Artemisinin-Resistant Plasmodium falciparum in Africa","volume":"376","author":"F Lu","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"pone.0339317.ref051","article-title":"Identification of potential inhibitors of casein kinase 2 alpha of Plasmodium falciparum with potent in vitro activity","volume":"67","author":"KCP Tomaz","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"pone.0339317.ref052","doi-asserted-by":"crossref","first-page":"10579","DOI":"10.1007\/s11033-022-07625-5","article-title":"An update on cerebral malaria for therapeutic intervention","volume":"49","author":"C Panda","year":"2022","journal-title":"Mol Biol Rep"},{"key":"pone.0339317.ref053","doi-asserted-by":"crossref","first-page":"819469","DOI":"10.3389\/fimmu.2021.819469","article-title":"Oral Therapy Using a Combination of Nanotized Antimalarials and Immunomodulatory Molecules Reduces Inflammation and Prevents Parasite Induced Pathology in the Brain and Spleen of P. berghei ANKA Infected C57BL\/6 Mice","volume":"12","author":"S Mukherjee","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"pone.0339317.ref054","doi-asserted-by":"crossref","DOI":"10.2144\/fsoa-2020-0209","article-title":"Structured data sets of compounds with multi-target and corresponding single-target activity from biological assays","volume":"7","author":"C Feldmann","year":"2021","journal-title":"Future Sci OA"},{"key":"pone.0339317.ref055","article-title":"Evaluation of acute oral toxicity of zinc oxide nanoparticles in rats","author":"E Shaban","year":"2021","journal-title":"Egypt J Chem"},{"issue":"30","key":"pone.0339317.ref056","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1200\/JCO.22.00371","article-title":"Improving Dose-Optimization Processes Used in Oncology Drug Development to Minimize Toxicity and Maximize Benefit to Patients","volume":"40","author":"J Fourie Zirkelbach","year":"2022","journal-title":"J Clin Oncol"},{"issue":"3","key":"pone.0339317.ref057","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s00044-017-2107-3","article-title":"Molecular modeling studies of bromopyrrole alkaloids as potential antimalarial compounds: a DFT approach","volume":"27","author":"MC Flores","year":"2017","journal-title":"Med Chem Res"},{"key":"pone.0339317.ref058","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1747519820932091","article-title":"Theoretical investigations on the HOMO\u2013LUMO gap and global reactivity descriptor studies, natural bond orbital, and nucleus-independent chemical shifts analyses of 3-phenylbenzo[d]thiazole-2(3H)-imine and its para-substituted derivatives: Solvent and substituent effects","volume":"45","author":"M Miar","year":"2020","journal-title":"Journal of Chemical Research"},{"issue":"8","key":"pone.0339317.ref059","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268269","article-title":"Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors","volume":"17","author":"AJ Owoloye","year":"2022","journal-title":"PLoS One"},{"key":"pone.0339317.ref060","unstructured":"Kamunya SG. Design of Selective Plasmodium falciparum Kinase Inhibitors using Computer-Aided Drug Discovery. 2022."},{"issue":"17","key":"pone.0339317.ref061","doi-asserted-by":"crossref","first-page":"8958","DOI":"10.1080\/07391102.2023.2249111","article-title":"Exploring potential Plasmodium kinase inhibitors: a combined docking, MD and QSAR studies","volume":"42","author":"SG Kankinou","year":"2024","journal-title":"J Biomol Struct Dyn"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0339317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T18:40:43Z","timestamp":1768329643000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0339317"}},"subtitle":[],"editor":[{"given":"Yusuf Oloruntoyin","family":"Ayipo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0339317","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]}}}